We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

Mexican health-care market estimated to gain 6.8 percent compounded annually
  • Shook Hardy & Bacon LLP
  • USA, Mexico
  • August 21 2014

Research and consulting firm GlobalData reports that Mexico's health-care market, including both the pharmaceutical and medical device sectors, will


Physicians urge FDA to allow distinctive names for biosimilars
  • Shook Hardy & Bacon LLP
  • USA
  • August 21 2014

A coalition of organizations representing specialist physicians and individual physicians have authored a letter to U.S. Food and Drug Administration


Tech interests praise USPTO director nomination
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

According to a news source, technology industry interests have lauded President Barack Obama's (D) choice for U.S. Patent and Trademark Office


Biotech boards dominated by men
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A Liftstream analysis reportedly shows that the average Board of Directors in the biotechnology sphere is roughly 90 percent male and more than half


Nagoya genetic resources protocol enters into force
  • Shook Hardy & Bacon LLP
  • Global, USA
  • October 30 2014

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization entered into force


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


Third Circuit revives shareholder suit over dissolved biotech company
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a


Ninth Circuit okays pharma waste disposal ordinance
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The Ninth Circuit Court of Appeals has upheld the validity of an Alameda County ordinance that requires prescription drug producers that sell brand


Considering end-user interests in patent-law reforms
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

Seton Hall University School of Law Professor Gaia Bernstein analyzes the rising role of end users in the patent-litigation landscape and argues that


New infringement lawsuit filed to protect BRCA1 and BRCA2 patents
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

Myriad Genetics has brought a new infringement lawsuit against a company offering a next-generation sequencing test that analyzes the BRCA1 and BRCA2